Cat. #162350
EYFP CH12F3 cell line
Cat. #: 162350
Sub-type: Continuous
Unit size: 1x10^6 cells / vial
Organism: Mouse
Tissue: Blood
Disease: Lymphoma
Model: Transgenic
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Bodil Merete Kavli
Institute: Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: EYFP CH12F3 cell line
- Cancer: Blood cancer
- Tool sub type: Continuous
- Organism: Mouse
- Tissue: Blood
- Disease: Lymphoma
- Model: Transgenic
- Model description: EYFP expression using CRISPR-Cas9
- Crispr: Yes
- Description: Mouse B lymphocyte cell line expressing enhanced yellow fluorescent protein
- Biosafety level: 2
Target Details
- Target: AID
Handling
- Format: Frozen
- Passage number: Mouse B lymphocyte cell line expressing EYFP
- Growth medium: RPMI culture medium supplemented with 10% heat-inactivated foetal calf serum, 0.03% l-glutamine, 50 M -mercaptoethanol, 1 mM sodium pyruvate, 0.1 mg/ml penicillin/streptomycin, 2.3 g/ml fungizone, and 1.0 mg/ml G419
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
- Cultured in antibiotics: Yes, penicillin/streptomycin
References
- Pettersen et al., 2015. DNA Repair (Amst). 25:60-71, PMID: 25486549
